Table 1 Baseline demographics in patients undergoing pancreatectomy
Characteristic | All (n = 110) | PG group (n = 51) | PJ group (n = 59) | P value |
|---|---|---|---|---|
Age* | 58.9 ± 1.0 | 60.9 ± 1.3 | 57.1 ± 1.5 | 0.07 |
Men, n (%) | 65 (59.1) | 27 (52.9) | 38 (64.4) | 0.22 |
BMI*, kg/m2 | 23.0 ± 0.3 | 22.6 ± 0.6 | 23.3 ± 0.4 | 0.28 |
Comorbidities, n (%) | ||||
 Diabetes mellitus, n (%) | 22 (20) | 9 (17.6) | 13 (22.0) | 0.57 |
 Hypertension, n (%) | 27 (24.5) | 13 (25.5) | 14 (23.7) | 0.83 |
Operation time*, min | 368.0 ± 8.2 | 342.4 ± 11.7 | 390.0 ± 10.8 | < 0.01 |
ASA ≥ 3, n (%) | 19 (17.3) | 9 (17.6) | 10 (16.9) | 0.92 |
Intraoperative blood transfusion, n (%) | 41 (37.3) | 14 (27.5) | 27 (45.8) | 0.048 |
Estimated blood loss*, mL | 502.4 ± 48.3 | 392.2 ± 31.8 | 597.6 ± 84.2 | 0.03 |
Pancreatic gland texture, n (%) | 0.55 | |||
 Soft, n (%) | 93 (84.5) | 42 (82.4) | 51 (86.4) | – |
 Hard, n (%) | 17 (15.5) | 9 (17.6) | 8 (13.6) | – |
Mesh materials, n (%) | < 0.01 | |||
 Non-absorbable, n (%) | 59 (53.6) | 10 (19.6) | 49 (83.1) | – |
 Absorbable, n (%) | 51 (46.4) | 41 (80.4) | 10 (16.9) | – |
Pancreatic duct size (> 4 mm), n (%) | 28 (25.5) | 14 (27.5) | 14 (23.7) | 0.66 |
The time of anastomosis*, min | 27.4 ± 0.4 | 29.1 ± 0.7 | 27.9 ± 0.6 | 0.21 |